Sakar Healthcar Consolidated September 2024 Net Sales at Rs 42.78 crore, up 25.53 percent Y-o-Y - Moneycontrol
| SAKAR Stock | 249.10 2.20 0.89% |
About 53% of Sakar Healthcare's investor base is interested to short. The analysis of overall sentiment of trading Sakar Healthcare Limited stock suggests that many investors are impartial at this time. Sakar Healthcare's investing sentiment overview a quick insight into current market opportunities from investing in Sakar Healthcare Limited. Many technical investors use Sakar Healthcare stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Sakar |
Sakar Healthcar Consolidated September 2024 Net Sales at Rs 42.78 crore, up 25.53 percent Y-o-Y Moneycontrol
Read at news.google.com
 |
Sakar Healthcare Fundamental Analysis
We analyze Sakar Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sakar Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sakar Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Sakar Healthcare is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Sakar Healthcare Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sakar Healthcare stock to make a market-neutral strategy. Peer analysis of Sakar Healthcare could also be used in its relative valuation, which is a method of valuing Sakar Healthcare by comparing valuation metrics with similar companies.
Peers
Sakar Healthcare Related Equities
| CTE | Cambridge Technology | 4.21 | ||||
| UBL | United Breweries | 0.17 | ||||
| COMPUSOFT | Compucom Software | 0.25 | ||||
| SDBL | Som Distilleries | 0.70 | ||||
| KAYNES | Kaynes Technology | 1.82 | ||||
| GTECJAINX | G Tec | 2.03 | ||||
| CAMS | Computer Age | 2.12 | ||||
| UMESLTD | Usha Martin | 4.68 |
Other Information on Investing in Sakar Stock
Sakar Healthcare financial ratios help investors to determine whether Sakar Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sakar with respect to the benefits of owning Sakar Healthcare security.